These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 10835628)

  • 1. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema.
    Karkkainen MJ; Ferrell RE; Lawrence EC; Kimak MA; Levinson KL; McTigue MA; Alitalo K; Finegold DN
    Nat Genet; 2000 Jun; 25(2):153-9. PubMed ID: 10835628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of murine Flt4 ligand/VEGF-C.
    Fitz LJ; Morris JC; Towler P; Long A; Burgess P; Greco R; Wang J; Gassaway R; Nickbarg E; Kovacic S; Ciarletta A; Giannotti J; Finnerty H; Zollner R; Beier DR; Leak LV; Turner KJ; Wood CR
    Oncogene; 1997 Jul; 15(5):613-8. PubMed ID: 9247316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recessive primary congenital lymphoedema caused by a VEGFR3 mutation.
    Ghalamkarpour A; Holnthoner W; Saharinen P; Boon LM; Mulliken JB; Alitalo K; Vikkula M
    J Med Genet; 2009 Jun; 46(6):399-404. PubMed ID: 19289394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice.
    Veikkola T; Jussila L; Makinen T; Karpanen T; Jeltsch M; Petrova TV; Kubo H; Thurston G; McDonald DM; Achen MG; Stacker SA; Alitalo K
    EMBO J; 2001 Mar; 20(6):1223-31. PubMed ID: 11250889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase.
    Irrthum A; Karkkainen MJ; Devriendt K; Alitalo K; Vikkula M
    Am J Hum Genet; 2000 Aug; 67(2):295-301. PubMed ID: 10856194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric VEGFRs are activated by a small-molecule dimerizer and mediate downstream signalling cascades in endothelial cells.
    Knight EL; Warner AJ; Maxwell A; Prigent SA
    Oncogene; 2000 Nov; 19(47):5398-405. PubMed ID: 11103941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical variability in a Japanese hereditary lymphedema type I family with an FLT4 mutation.
    Mizuno S; Yamada Y; Yamada K; Nomura N; Wakamatsu N
    Congenit Anom (Kyoto); 2005 Jun; 45(2):59-61. PubMed ID: 15904433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3.
    Mäkinen T; Jussila L; Veikkola T; Karpanen T; Kettunen MI; Pulkkanen KJ; Kauppinen R; Jackson DG; Kubo H; Nishikawa S; Ylä-Herttuala S; Alitalo K
    Nat Med; 2001 Feb; 7(2):199-205. PubMed ID: 11175851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase.
    Qi JH; Claesson-Welsh L
    Exp Cell Res; 2001 Feb; 263(1):173-82. PubMed ID: 11161716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functionally active VEGF fusion proteins.
    Backer MV; Backer JM
    Protein Expr Purif; 2001 Oct; 23(1):1-7. PubMed ID: 11570839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-VEGFR-2 scFvs for cell isolation. Single-chain antibodies recognizing the human vascular endothelial growth factor receptor-2 (VEGFR-2/flk-1) on the surface of primary endothelial cells and preselected CD34+ cells from cord blood.
    Böldicke T; Tesar M; Griesel C; Rohde M; Gröne HJ; Waltenberger J; Kollet O; Lapidot T; Yayon A; Weich H
    Stem Cells; 2001; 19(1):24-36. PubMed ID: 11209088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis.
    Karkkainen MJ; Petrova TV
    Oncogene; 2000 Nov; 19(49):5598-605. PubMed ID: 11114740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium.
    Paavonen K; Mandelin J; Partanen T; Jussila L; Li TF; Ristimaki A; Alitalo K; Konttinen YT
    J Rheumatol; 2002 Jan; 29(1):39-45. PubMed ID: 11824969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative splicing of the human VEGFGR-3/FLT4 gene as a consequence of an integrated human endogenous retrovirus.
    Hughes DC
    J Mol Evol; 2001 Aug; 53(2):77-9. PubMed ID: 11479678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
    Partanen TA; Paavonen K
    Microsc Res Tech; 2001 Oct; 55(2):108-21. PubMed ID: 11596156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology.
    Morini M; Benelli R; Giunciuglio D; Carlone S; Arena G; Noonan DM; Albini A
    Biochem Biophys Res Commun; 2000 Jun; 273(1):267-71. PubMed ID: 10873597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth.
    Karpanen T; Egeblad M; Karkkainen MJ; Kubo H; Ylä-Herttuala S; Jäättelä M; Alitalo K
    Cancer Res; 2001 Mar; 61(5):1786-90. PubMed ID: 11280723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation in vascular endothelial growth factor-C, a ligand for vascular endothelial growth factor receptor-3, is associated with autosomal dominant milroy-like primary lymphedema.
    Gordon K; Schulte D; Brice G; Simpson MA; Roukens MG; van Impel A; Connell F; Kalidas K; Jeffery S; Mortimer PS; Mansour S; Schulte-Merker S; Ostergaard P
    Circ Res; 2013 Mar; 112(6):956-60. PubMed ID: 23410910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells.
    Takahashi T; Yamaguchi S; Chida K; Shibuya M
    EMBO J; 2001 Jun; 20(11):2768-78. PubMed ID: 11387210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.